Equillium (EQ) Insider Trading & Ownership $0.47 0.00 (-0.43%) As of 01:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Equillium (NASDAQ:EQ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$86,432.60 Get EQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Equillium stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EQ Insider Buying and Selling by Quarter Remove Ads Equillium Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/23/2025Jason A KeyesCFOSell10,000$0.65$6,500.00 11/14/2024Jason A KeyesCFOSell10,000$0.70$7,000.00 10/28/2024Christine ZedelmayerCOOSell15,000$1.25$18,750.00 10/28/2024Penny TomInsiderSell2,835$1.25$3,543.75 10/25/2024Penny TomInsiderSell683$1.25$853.75 9/26/2024Jason A KeyesCFOSell10,000$0.81$8,100.00 9/16/2024Penny TomInsiderSell38,806$0.85$32,985.10 7/16/2024Jason A KeyesCFOSell10,000$0.87$8,700.00 (Data available from 1/1/2013 forward) EQ Insider Trading Activity - Frequently Asked Questions Who is on Equillium's Insider Roster? The list of insiders at Equillium includes Christine Zedelmayer, Jason A Keyes, and Penny Tom. Learn more on insiders at EQ. What percentage of Equillium stock is owned by insiders? 30.30% of Equillium stock is owned by insiders. Learn more on EQ's insider holdings. Which Equillium insiders have been selling company stock? The following insiders have sold EQ shares in the last 24 months: Christine Zedelmayer ($18,750.00), Jason A Keyes ($30,300.00), and Penny Tom ($37,382.60). How much insider selling is happening at Equillium? Insiders have sold a total of 97,324 Equillium shares in the last 24 months for a total of $86,432.60 sold. Equillium Key ExecutivesMr. Daniel Mark Bradbury (Age 63)Executive Chairman Compensation: $158kMr. Bruce D. Steel C.F.A. (Age 58)Co-Founder, President, CEO & Director Compensation: $779.87kMs. Christine Zedelmayer M.B.A. (Age 54)P.M.P., Senior VP & COO Compensation: $553.73k1 recent tradesDr. Stephen Connelly Ph.D. (Age 42)Chief Scientific Officer & Director Compensation: $571.32kMr. Jason A. Keyes (Age 53)Chief Financial Officer 2 recent tradesPenny TomSenior VP of Finance & Principal Accounting Officer2 recent tradesMr. Michael MooreVice President of Investor Relations & Corporate CommunicationsDr. Matthew Ritter Ph.D.Senior Vice President of Corporate DevelopmentMr. Joel M. Rothman (Age 55)Chief Development Officer Dr. Maple Fung M.D.Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Editas Medicine Insider Buying Elutia Insider Buying Renovaro Insider Buying Adverum Biotechnologies Insider Buying Coya Therapeutics Insider Buying Coherus BioSciences Insider Buying Milestone Pharmaceuticals Insider Buying Fate Therapeutics Insider Buying Nkarta Insider Buying Immunic Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:EQ) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow you could profit from Elon’s latest AI breakthroughEvery single one of Elon's projects minted an entire new class of millionaires. And xAI could be next in li...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Fair warning: this will not make for easy viewing. Especially if you voted for Trump, put your faith in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equillium, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equillium With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.